(Q58996996)

6

0 references

Marie-Rose Christiaens

8

object named as

Marie-Rose Christiaens

0 references

author name string

Ann Smeets

1

0 references

Barbara Brouwers

2

0 references

Sigrid Hatse

3

0 references

Robert Paridaens

5

0 references

Hans Wildiers

Creative Commons Attribution 3.0 Unported

7

0 references

publication date

2013

0 references

published in

ISRN Immunology

0 references

volume

2013

0 references

page(s)

1-5

0 references

copyright license

start time

29 May 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F453561

CCL5-mediated endogenous antitumor immunity elicited by adoptively transferred lymphocytes and dendritic cell depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F453561

CCL5 as an adjuvant for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F453561

CCR5 antagonist blocks metastasis of basal breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F453561

Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F453561

Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F453561

Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F453561

The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F453561

Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F453561

Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F453561

Expression of CCL5 (RANTES) and CCR5 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F453561

CCL5/CCR5 axis promotes the motility of human oral cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F453561

New insights into chronic inflammation-induced immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F453561

Immune therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F453561